Should We Move Up the Clock on Preventive Intervention in Marfan's Disease?
02 December 2018
07 January 2019
28 February 2019 (online)
Gradual dilatation of the ascending aorta is a common phenomenon in patients with Marfan's disease, which often leads to dissection and rupture. It is estimated that around two-thirds of the patients either die or require major surgery before the age of 42 years. In the mirror of the experience of 40 years with aortic wall reinforcement, the author forward the postulate that whenever the ascending aorta of an individual with proven Marfan's disease reaches adult size, that is, approximately 3.5 cm in diameter, the wall of his/her ascending aorta should be reinforced to prevent further expansion.
- 1 Robicsek F, Daugherty HK, Mullen DC. External grafting of aortic aneurysms. J Thorac Cardiovasc Surg 1971; 61 (01) 131-134
- 2 Robicsek F, Cook JW, Reames Sr MK, Skipper ER. Size reduction ascending aortoplasty: is it dead or alive?. J Thorac Cardiovasc Surg 2004; 128 (04) 562-570
- 3 Robicsek F, Thubrikar M. The mechanism and prevention of aortic dissection in Marfan syndrome. In: Hetzer R, Gehle P, Ennker J. , eds. Cardiovascular Aspects of Marfan Syndrome. Darmstadt: Steinkopff; 1995: 61-70